Head-to-head · free
Science Applications International Corp. vs Sabra Healthcare REIT
SAIC vs SBRA — return on capital, cash generation, margins and balance sheet side by side.
SAIC
4 / 7
measures where SAIC leads
SBRA
3 / 7
measures where SBRA leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | SAIC · FY2026 | SBRA · FY2025 |
|---|---|---|
| Revenue | $7.3B | $774.6M |
| Net income | — | $155.6M |
| Revenue growth (yearly, multi-year) | -0.4% | 8.0% |
| Free cash flow | $577.0M | — |
| Free cash flow margin | 7.9% | — |
| Net cash / (debt) | — | — |
| ROIC | 11.8% | 4.8% |
| Return on equity | 23.3% | 5.6% |
| Gross margin | 12.0% | 65.0% |
| Operating margin | 7.2% | 34.1% |
| Net debt / EBITDA | 3.44x | 5.55x |
Figures are as reported by each company; latest fiscal year shown.
Where Science Applications International Corp.'s cash went (FY2026)
- Capital spending
- $32.0M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Sabra Healthcare REIT's cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free